TP53 and non-small cell lung carcinoma: Of note, both the very low TMB (mean < 3, Figure 2A) and the very low TP53 mutation rate (about 20–25%, Figure 2B) are unique features of ALK+ tumors distinguishing them from all other NSCLC [18, 38].